Latest news
Why Did IOVA, REPL, ROKU Stocks Surge To 52-Week Highs Today? - TradingViewTradingView · Fri, 07 Aug 2026 02:40:00 GMTIovance Biotherapeutics reports record Q2 revenue ~$99.3M, gross margin 56% - TradingViewTradingView · Thu, 06 Aug 2026 11:13:01 GMTTIL Q2'26 Earnings: EPS estimate is (0.35) USD - TradingViewTradingView · Thu, 06 Aug 2026 11:00:36 GMTTIL Ltd. Revenue Breakdown – NSE:TIL - TradingViewTradingView · Sat, 01 Aug 2026 07:13:58 GMT